1. Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective. (1st February 2019) Authors: Hildick-Smith, David; Turner, Mark; Shaw, Louise; Nakum, Mitesh; Hartaigh, Bríain Ó; Evans, Richard M.; Rhodes, John F.; Sondergaard, Lars; Kasner, Scott E. Journal: Journal of medical economics Issue: Volume 22:Number 2(2019) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population. (1st January 2021) Authors: Mantel, Jack; Chitnis, Abhishek S.; Ruppenkamp, Jill; Holy, Chantal E.; Daccach, Juan Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants. (1st February 2020) Authors: Ledbetter, Joel; Brannman, Lance; Wade, Sally W.; Gonzales, Tara; Kong, Amanda M. Journal: Journal of medical economics Issue: Volume 23:Number 2(2020) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty. (2nd December 2019) Authors: Asche, Carl V.; Dagenais, Simon; Kang, Amiee; Ren, Jinma; Maurer, Brian T. Journal: Journal of medical economics Issue: Volume 22:Number 12(2020) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions. (2nd January 2019) Authors: Asche, Carl V.; Dagenais, Simon; Kang, Amiee; Ren, Jinma; Maurer, Brian T. Journal: Journal of medical economics Issue: Volume 22:Number 1(2019) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Migraine burden and costs in France: a nationwide claims database analysis of triptan users. (3rd July 2019) Authors: Donnet, Anne; Emery, Corinne; Aly, Samia; Allaf, Bashar; Cayre, Fanny; Mahieu, Nicolas; Gourmelen, Julie; Levy, Pierre; Fagnani, Francis Journal: Journal of medical economics Issue: Volume 22:Number 7(2019) Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease. (2nd April 2020) Authors: Elsaid, Mohamed I.; Rustgi, Vinod K.; Loo, Nicole; Aggarwal, Kavita; Li-McLeod, Josephine; Niu, Xiaoli; Poordad, Fred Journal: Journal of medical economics Issue: Volume 23:Number 4(2020) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The healthcare burden of disease progression in medicare patients with functional mitral regurgitation. (2nd September 2019) Authors: McCullough, Peter A.; Mehta, Hirsch S.; Cork, David P.; Barker, Colin M.; Gunnarsson, Candace; Mollenkopf, Sarah; Van Houten, Joanna; Verta, Patrick Journal: Journal of medical economics Issue: Volume 22:Number 9(2019) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗